India Drug Device Combination Products Market Size & Outlook

The drug device combination products market in India is expected to reach a projected revenue of US$ 11,774.8 million by 2030. A compound annual growth rate of 9% is expected of India drug device combination products market from 2024 to 2030.
Revenue, 2023 (US$M)
$6,441.1
Forecast, 2030 (US$M)
$11,774.8
CAGR, 2024 - 2030
9%
Report Coverage
India

India drug device combination products market, 2018-2030 (US$M)

India

Related Markets

India drug device combination products market highlights

  • The India drug device combination products market generated a revenue of USD 6,441.1 million in 2023 and is expected to reach USD 11,774.8 million by 2030.
  • The India market is expected to grow at a CAGR of 9% from 2024 to 2030.
  • In terms of segment, transdermal patches was the largest revenue generating product in 2023.
  • Infusion Pumps is the most lucrative product segment registering the fastest growth during the forecast period.


Drug device combination products market data book summary

Market revenue in 2023USD 6,441.1 million
Market revenue in 2030USD 11,774.8 million
Growth rate9% (CAGR from 2023 to 2030)
Largest segmentTransdermal patches
Fastest growing segmentInfusion Pumps
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPhotodynamic Therapy Devices, Transdermal Patches, Wound Care Products, Infusion Pumps, Orthopedic Combination Products, Drug Eluting Stents, Inhalers, Antimicrobial Catheters
Key market players worldwideAbbott Laboratories, Terumo Corp, Stryker Corp, Viatris Inc, Medtronic PLC, Boston Scientific Corp, Novartis AG ADR, Becton Dickinson & Co, Teleflex Inc, W L Gore & Associates


Other key industry trends

  • In terms of revenue, India accounted for 4.7% of the global drug device combination products market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China drug device combination products market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 16,994.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Drug Device Combination Products Market Companies

Name Profile # Employees HQ Website

India drug device combination products market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug device combination products market will help companies and investors design strategic landscapes.


Transdermal patches was the largest segment with a revenue share of 23.25% in 2023. Horizon Databook has segmented the India drug device combination products market based on photodynamic therapy devices, transdermal patches, wound care products, infusion pumps, orthopedic combination products, drug eluting stents, inhalers, antimicrobial catheters covering the revenue growth of each sub-segment from 2018 to 2030.


India’s relatively liberal laws governing the use of medical devices and increasing healthcare spending are among the main factors driving the adoption of drug-device combination products. In addition, the opening of new corporate hospitals, the introduction of organized training programs, and awareness campaigns related to drug-device combination products are expected to propel market growth over the forecast period.

India is one of the top three countries in terms of diabetes prevalence. According to WHO, in 2021, nearly 77 million people were living with diabetes in India, and an estimated 8.7% of people with diabetes were aged between 20 and 70 years. Indians are more likely to develop diabetes than people in other parts of the world, such as the Americas & Europe. This is due to the Indian diet being high in carbohydrates and saturated fats, which adds more sugar & calories to the body than it needs.

In addition, the growing prevalence of sedentary lifestyles and obesity are contributing to the high prevalence of diabetes. Hence, the high prevalence of chronic diseases in India is expected to drive the demand for drug-device combination products during the forecast period.

Reasons to subscribe to India drug device combination products market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of India drug device combination products market databook

  • Our clientele includes a mix of drug device combination products market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the India drug device combination products market , including forecasts for subscribers. This country databook contains high-level insights into India drug device combination products market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

India drug device combination products market size, by product, 2018-2030 (US$M)

India Drug Device Combination Products Market Outlook Share, 2023 & 2030 (US$M)

India drug device combination products market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more